Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.

MLA

Rosenkranz, Stephan, et al. “Selonsertib in Adults with Pulmonary Arterial Hypertension (ARROW): A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial.” The Lancet. Respiratory Medicine, vol. 10, no. 1, Jan. 2022, pp. 35–46. EBSCOhost, https://doi.org/10.1016/S2213-2600(21)00032-1.

APA

Rosenkranz, S., Feldman, J., McLaughlin, V. V., Rischard, F., Lange, T. J., White, R. J., Peacock, A. J., Gerhardt, F., Ebrahimi, R., Brooks, G., Satler, C., & Frantz, R. P. (2022). Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. Respiratory Medicine, 10(1), 35–46. https://doi.org/10.1016/S2213-2600(21)00032-1

Chicago

Rosenkranz, Stephan, Jeremy Feldman, Vallerie V McLaughlin, Franz Rischard, Tobias J Lange, R James White, Andrew J Peacock, et al. 2022. “Selonsertib in Adults with Pulmonary Arterial Hypertension (ARROW): A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial.” The Lancet. Respiratory Medicine 10 (1): 35–46. doi:10.1016/S2213-2600(21)00032-1.